Inducible co-stimulator null MRL-Faslpr mice:: Uncoupling of autoantibodies and T cell responses in lupus

MRL/Mpj-Tnfrsf6 (Ipr) (MRL-Fas(Ipr)) mice develop a spontaneous T cell-dependent autoimmune disease that shares features with human lupus, including fatal nephritis, systemic pathology, and autoantibodies (autoAb). The inducible co-stimulator (ICOS) is upregulated on activated T cells and modulates T cell-mediated responses. To investigate whether ICOS has an essential role in regulating autoimmune lupus nephritis and the systemic illness in MRL-Fas(Ipr) mice, ICOS null (-/-) MRL Fas(Ipr) and ICOS intact (+/+) MRL-Fas(Ipr) strains (wild-type [WT]) were generated and compared. It was determined that in ICOS-/- MRL-Fas(Ipr) as compared with the WT strain, (1) there is a significant reduction in circulating IgG and double-stranded DNA autoantibody isotype titers, and (2) there is an amplification of the frequency of intrarenal T cells generating IFN-gamma and TNF-alpha in ICOS-/- versus WT mice. Of note, eliminating ICOS in the MRL-Fas(Ipr) strain does not alter renal pathology or function. Despite the reduction in circulating IgG and autoantibody isotypes (G1, G2a, and G2b), the amount of these IgG isotypes depositing in kidneys is similar. Furthermore, the systemic illness (skin, salivary and lacrimal glands, lungs, lymphadenopathy, and splenomegaly) is equivalent in ICOS-/- MRL-Fas(Ipr) and WT mice. These findings highlight the danger of relying on individual parameters, such as quantitative serum Ig levels and T cell functions, as prognostic indicators of lupus.